Hefei National Laboratory for Physical Sciences at Microscale, CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences, University of Science and Technology of China, 230027, Hefei, China.
School of Data Science, University of Science and Technology of China, 230026, Hefei, China.
Cell Mol Immunol. 2019 Mar;16(3):216-224. doi: 10.1038/s41423-019-0208-2. Epub 2019 Feb 20.
Although lymphocytes are known to circulate throughout lymphoid tissues and blood, they also establish residency in nonlymphoid organs, most prominently in barrier tissues, such as the intestines. The adaptation of T lymphocytes to intestinal environments requires constant discrimination between natural stimulation from commensal flora and food and pathogens that need to be cleared. Genetic variations that cause a defective defense or a break in tolerance along with environmental cues, such as infection or imbalances in the gut microbiota known as dysbiosis, can trigger several immune disorders via the activation of T lymphocytes in the intestines. Elucidation of the immune mechanisms that distinguish between commensal flora and pathogenic organisms may reveal therapeutic targets for the prevention or modulation of inflammatory diseases and boost the efficacy of cancer immunotherapy. In this review, we discuss the development and adaptation of T lymphocytes in the intestine, how these cells protect the host against pathogenic infections while tolerating food antigens and commensal microbiota, and the potential implications of targeting these cells for disease management and therapeutics.
虽然淋巴细胞已知会在淋巴组织和血液中循环,但它们也会在非淋巴器官中定居,尤其是在屏障组织中,如肠道。T 淋巴细胞适应肠道环境需要不断区分来自共生菌群和食物的自然刺激与需要清除的病原体。遗传变异会导致防御缺陷或耐受破裂,加上感染或称为肠道菌群失调的肠道微生物群落失衡等环境线索,可通过肠道 T 淋巴细胞的激活引发多种免疫紊乱。阐明区分共生菌群和病原体的免疫机制可能会为预防或调节炎症性疾病以及提高癌症免疫疗法的疗效提供治疗靶点。在这篇综述中,我们讨论了 T 淋巴细胞在肠道中的发育和适应性,这些细胞如何在耐受食物抗原和共生菌群的同时保护宿主免受病原感染,以及针对这些细胞进行疾病管理和治疗的潜在意义。